WebAug 10, 2024 · His deep experience in genetic medicines and metabolic diseases will serve LogicBio well as we look to execute on our goals for both the GeneRide and Next Generation Capsid platforms in search of... WebOct 3, 2024 · Fred Chereau, President and Chief Executive Officer, LogicBio, said, "Through this acquisition, we strive to accelerate our research in gene editing and AAV …
Fred Chereau, CEO of LogicBio Therapeutics at The Advanced
WebOct 3, 2024 · LogicBio has developed technology platforms for the delivery and insertion of genes to address genetic diseases, as well as a platform designed to improve viral vector manufacturing processes.... WebOct 3, 2024 · Fred Chereau, president and CEO of LogicBio, stated the company is “excited about the opportunity” to bring its “science and expertise in genetic medicine to Alexion.” ... LogicBio shares climbed to … chief sealth international high school adress
Frederic Chereau Net Worth, Biography, and Insider Trading
WebDec 22, 2024 · "We believe reporting interim data from SUNRISE in the second quarter of 2024 instead of by year-end 2024 will allow us to amass a more robust and meaningful data set," said Fred Chereau, president and chief executive officer of LogicBio. "Safety is our top priority, and we are pleased that the patient who experienced the SAE is now fully ... WebNov 15, 2024 · LEXINGTON, Mass., December 22, 2024 - LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial and development pipeline, and announced the appointment of Susan R. Kahn to its Board of Directors. SUNRISE Phase 1/2 Clinical … WebSep 19, 2024 · The colleagues of Fred Chéreau. At LogicBio Therapeutics, Fred Chéreau has 19 colleagues including Susan Kahn (Director), Richard Moscicki (Chairman of the … chief sealth interurban hiking- biking trail